Protein Therapeutics in Medical Biotechnology

Vocabulary flashcards related to Protein Therapeutics in Medical Biotechnology.

Protein Therapeutics

Highly specific and complex functions proteins that cannot be replaced by small molecules.

Recombinant DNA Technology

The technology used to create the majority of proteins for therapeutic purposes.

Immunogenicity

The tendency of protein-based therapeutics to trigger an unwanted immune response.

Polyethylene Glycol (PEG)

A substance used to enhance the stability and half-life of therapeutic proteins.

Gene Therapy

A therapeutic approach involving the replacement of deficient or abnormal proteins.

Biopharmaceuticals

Products produced by biological processes, including therapeutic proteins.

Clinical Trials

Research studies that evaluate the safety and effectiveness of medical treatments in humans.

Monoclonal Antibodies

Antibodies that are made by identical immune cells and are used in targeted therapies.

Antibody-Drug Conjugates (ADCs)

Cancer therapies that combine antibodies with drugs to specifically target cancer cells.

FDA Approval

Process by which the U.S. Food and Drug Administration reviews and approves drugs for public use.

Erythropoietin (EPO)

A modified protein that stimulates red blood cell production in the bone marrow.

Biomarkers

Biological substances that indicate a process or condition, used for diagnosis and treatment monitoring.

Pharmacological Classification

The categorization of protein therapeutics based on their mechanism of action and therapeutic effects.

Personalized Medicine

Medical care tailored to the individual characteristics of each patient, especially in the context of therapy.

Vaccine Development

The process of creating vaccines, often utilizing recombinant protein technology.